1 Introduction to Research & Analysis Reports
1.1 Alzheimer Treatment Drug Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Alzheimer Treatment Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Alzheimer Treatment Drug Overall Market Size
2.1 Global Alzheimer Treatment Drug Market Size: 2022 VS 2029
2.2 Global Alzheimer Treatment Drug Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Alzheimer Treatment Drug Sales: 2018-2029
3 Company Landscape
3.1 Top Alzheimer Treatment Drug Players in Global Market
3.2 Top Global Alzheimer Treatment Drug Companies Ranked by Revenue
3.3 Global Alzheimer Treatment Drug Revenue by Companies
3.4 Global Alzheimer Treatment Drug Sales by Companies
3.5 Global Alzheimer Treatment Drug Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Alzheimer Treatment Drug Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Alzheimer Treatment Drug Product Type
3.8 Tier 1, Tier 2 and Tier 3 Alzheimer Treatment Drug Players in Global Market
3.8.1 List of Global Tier 1 Alzheimer Treatment Drug Companies
3.8.2 List of Global Tier 2 and Tier 3 Alzheimer Treatment Drug Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Alzheimer Treatment Drug Market Size Markets, 2022 & 2029
4.1.2 Donepezil
4.1.3 Memantine
4.1.4 Rivastigmine
4.1.5 Other
4.2 By Type – Global Alzheimer Treatment Drug Revenue & Forecasts
4.2.1 By Type – Global Alzheimer Treatment Drug Revenue, 2018-2023
4.2.2 By Type – Global Alzheimer Treatment Drug Revenue, 2024-2029
4.2.3 By Type – Global Alzheimer Treatment Drug Revenue Market Share, 2018-2029
4.3 By Type – Global Alzheimer Treatment Drug Sales & Forecasts
4.3.1 By Type – Global Alzheimer Treatment Drug Sales, 2018-2023
4.3.2 By Type – Global Alzheimer Treatment Drug Sales, 2024-2029
4.3.3 By Type – Global Alzheimer Treatment Drug Sales Market Share, 2018-2029
4.4 By Type – Global Alzheimer Treatment Drug Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Alzheimer Treatment Drug Market Size, 2022 & 2029
5.1.2 Early to Moderate Stages
5.1.3 Moderate to Severe Stages
5.2 By Application – Global Alzheimer Treatment Drug Revenue & Forecasts
5.2.1 By Application – Global Alzheimer Treatment Drug Revenue, 2018-2023
5.2.2 By Application – Global Alzheimer Treatment Drug Revenue, 2024-2029
5.2.3 By Application – Global Alzheimer Treatment Drug Revenue Market Share, 2018-2029
5.3 By Application – Global Alzheimer Treatment Drug Sales & Forecasts
5.3.1 By Application – Global Alzheimer Treatment Drug Sales, 2018-2023
5.3.2 By Application – Global Alzheimer Treatment Drug Sales, 2024-2029
5.3.3 By Application – Global Alzheimer Treatment Drug Sales Market Share, 2018-2029
5.4 By Application – Global Alzheimer Treatment Drug Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Alzheimer Treatment Drug Market Size, 2022 & 2029
6.2 By Region – Global Alzheimer Treatment Drug Revenue & Forecasts
6.2.1 By Region – Global Alzheimer Treatment Drug Revenue, 2018-2023
6.2.2 By Region – Global Alzheimer Treatment Drug Revenue, 2024-2029
6.2.3 By Region – Global Alzheimer Treatment Drug Revenue Market Share, 2018-2029
6.3 By Region – Global Alzheimer Treatment Drug Sales & Forecasts
6.3.1 By Region – Global Alzheimer Treatment Drug Sales, 2018-2023
6.3.2 By Region – Global Alzheimer Treatment Drug Sales, 2024-2029
6.3.3 By Region – Global Alzheimer Treatment Drug Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Alzheimer Treatment Drug Revenue, 2018-2029
6.4.2 By Country – North America Alzheimer Treatment Drug Sales, 2018-2029
6.4.3 US Alzheimer Treatment Drug Market Size, 2018-2029
6.4.4 Canada Alzheimer Treatment Drug Market Size, 2018-2029
6.4.5 Mexico Alzheimer Treatment Drug Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Alzheimer Treatment Drug Revenue, 2018-2029
6.5.2 By Country – Europe Alzheimer Treatment Drug Sales, 2018-2029
6.5.3 Germany Alzheimer Treatment Drug Market Size, 2018-2029
6.5.4 France Alzheimer Treatment Drug Market Size, 2018-2029
6.5.5 U.K. Alzheimer Treatment Drug Market Size, 2018-2029
6.5.6 Italy Alzheimer Treatment Drug Market Size, 2018-2029
6.5.7 Russia Alzheimer Treatment Drug Market Size, 2018-2029
6.5.8 Nordic Countries Alzheimer Treatment Drug Market Size, 2018-2029
6.5.9 Benelux Alzheimer Treatment Drug Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Alzheimer Treatment Drug Revenue, 2018-2029
6.6.2 By Region – Asia Alzheimer Treatment Drug Sales, 2018-2029
6.6.3 China Alzheimer Treatment Drug Market Size, 2018-2029
6.6.4 Japan Alzheimer Treatment Drug Market Size, 2018-2029
6.6.5 South Korea Alzheimer Treatment Drug Market Size, 2018-2029
6.6.6 Southeast Asia Alzheimer Treatment Drug Market Size, 2018-2029
6.6.7 India Alzheimer Treatment Drug Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Alzheimer Treatment Drug Revenue, 2018-2029
6.7.2 By Country – South America Alzheimer Treatment Drug Sales, 2018-2029
6.7.3 Brazil Alzheimer Treatment Drug Market Size, 2018-2029
6.7.4 Argentina Alzheimer Treatment Drug Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Alzheimer Treatment Drug Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Alzheimer Treatment Drug Sales, 2018-2029
6.8.3 Turkey Alzheimer Treatment Drug Market Size, 2018-2029
6.8.4 Israel Alzheimer Treatment Drug Market Size, 2018-2029
6.8.5 Saudi Arabia Alzheimer Treatment Drug Market Size, 2018-2029
6.8.6 UAE Alzheimer Treatment Drug Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Allergan
7.1.1 Allergan Company Summary
7.1.2 Allergan Business Overview
7.1.3 Allergan Alzheimer Treatment Drug Major Product Offerings
7.1.4 Allergan Alzheimer Treatment Drug Sales and Revenue in Global (2018-2023)
7.1.5 Allergan Key News & Latest Developments
7.2 Eisai
7.2.1 Eisai Company Summary
7.2.2 Eisai Business Overview
7.2.3 Eisai Alzheimer Treatment Drug Major Product Offerings
7.2.4 Eisai Alzheimer Treatment Drug Sales and Revenue in Global (2018-2023)
7.2.5 Eisai Key News & Latest Developments
7.3 Novartis
7.3.1 Novartis Company Summary
7.3.2 Novartis Business Overview
7.3.3 Novartis Alzheimer Treatment Drug Major Product Offerings
7.3.4 Novartis Alzheimer Treatment Drug Sales and Revenue in Global (2018-2023)
7.3.5 Novartis Key News & Latest Developments
7.4 Daiichi Sankyo
7.4.1 Daiichi Sankyo Company Summary
7.4.2 Daiichi Sankyo Business Overview
7.4.3 Daiichi Sankyo Alzheimer Treatment Drug Major Product Offerings
7.4.4 Daiichi Sankyo Alzheimer Treatment Drug Sales and Revenue in Global (2018-2023)
7.4.5 Daiichi Sankyo Key News & Latest Developments
7.5 Merz Pharma
7.5.1 Merz Pharma Company Summary
7.5.2 Merz Pharma Business Overview
7.5.3 Merz Pharma Alzheimer Treatment Drug Major Product Offerings
7.5.4 Merz Pharma Alzheimer Treatment Drug Sales and Revenue in Global (2018-2023)
7.5.5 Merz Pharma Key News & Latest Developments
7.6 Pfizer
7.6.1 Pfizer Company Summary
7.6.2 Pfizer Business Overview
7.6.3 Pfizer Alzheimer Treatment Drug Major Product Offerings
7.6.4 Pfizer Alzheimer Treatment Drug Sales and Revenue in Global (2018-2023)
7.6.5 Pfizer Key News & Latest Developments
7.7 Johnson & Johnson
7.7.1 Johnson & Johnson Company Summary
7.7.2 Johnson & Johnson Business Overview
7.7.3 Johnson & Johnson Alzheimer Treatment Drug Major Product Offerings
7.7.4 Johnson & Johnson Alzheimer Treatment Drug Sales and Revenue in Global (2018-2023)
7.7.5 Johnson & Johnson Key News & Latest Developments
7.8 Lundbeck
7.8.1 Lundbeck Company Summary
7.8.2 Lundbeck Business Overview
7.8.3 Lundbeck Alzheimer Treatment Drug Major Product Offerings
7.8.4 Lundbeck Alzheimer Treatment Drug Sales and Revenue in Global (2018-2023)
7.8.5 Lundbeck Key News & Latest Developments
8 Global Alzheimer Treatment Drug Production Capacity, Analysis
8.1 Global Alzheimer Treatment Drug Production Capacity, 2018-2029
8.2 Alzheimer Treatment Drug Production Capacity of Key Manufacturers in Global Market
8.3 Global Alzheimer Treatment Drug Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Alzheimer Treatment Drug Supply Chain Analysis
10.1 Alzheimer Treatment Drug Industry Value Chain
10.2 Alzheimer Treatment Drug Upstream Market
10.3 Alzheimer Treatment Drug Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Alzheimer Treatment Drug Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
世界のアルツハイマー病治療薬市場予測2023-2029：ドネペジル、メマンチン、リバスチグミン、その他 |
| 【英語タイトル】Alzheimer Treatment Drug Market, Global Outlook and Forecast 2023-2029 | |
 | ・商品コード：MMG23JU5642 ・発行会社（調査会社）：Market Monitor Global ・発行日：2023年6月 ・ページ数：72 ・レポート言語：英語 ・レポート形式：PDF ・納品方法：Eメール（受注後2-3営業日） ・調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど ・産業分野：医薬品＆医療 |
| Single User（1名様閲覧用） | USD3,250 ⇒換算￥494,000 | 見積依頼/購入/質問フォーム |
| Multi User（20名様閲覧用） | USD4,225 ⇒換算￥642,200 | 見積依頼/購入/質問フォーム |
| Enterprise User（閲覧人数制限なし） | USD4,875 ⇒換算￥741,000 | 見積依頼/購入/質問フォーム |
|
※販売価格オプションの説明 ※お支払金額：換算金額（日本円）＋消費税 ※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡） ※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能） |
| 当調査レポートは次の情報を含め、世界のアルツハイマー病治療薬市場規模と予測を収録しています。・世界のアルツハイマー病治療薬市場：売上、2018年-2023年、2024年-2029年 ・世界のアルツハイマー病治療薬市場：販売量、2018年-2023年、2024年-2029年 ・世界のトップ5企業、2022年 世界のアルツハイマー病治療薬市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「ドネペジル」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。 アルツハイマー病治療薬のグローバル主要企業は、Allergan、 Eisai、 Novartis、 Daiichi Sankyo、 Merz Pharma、 Pfizer、 Johnson & Johnson、 Lundbeckなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。 MARKET MONITOR GLOBAL（MMG）は、アルツハイマー病治療薬のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。 【セグメント別市場分析】 世界のアルツハイマー病治療薬市場：タイプ別、2018年-2023年、2024年-2029年 世界のアルツハイマー病治療薬市場：タイプ別市場シェア、2022年 ・ドネペジル、メマンチン、リバスチグミン、その他 世界のアルツハイマー病治療薬市場：用途別、2018年-2023年、2024年-2029年 世界のアルツハイマー病治療薬市場：用途別市場シェア、2022年 ・初期-中期、中等度-重症 世界のアルツハイマー病治療薬市場：地域・国別、2018年-2023年、2024年-2029年 世界のアルツハイマー病治療薬市場：地域別市場シェア、2022年 ・北米：アメリカ、カナダ、メキシコ ・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア ・アジア：中国、日本、韓国、東南アジア、インド ・南米：ブラジル、アルゼンチン ・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE 【競合分析】 また、当レポートは主要な市場参加者の分析を提供します。 ・主要企業におけるアルツハイマー病治療薬のグローバル売上、2018年-2023年 ・主要企業におけるアルツハイマー病治療薬のグローバル売上シェア、2022年 ・主要企業におけるアルツハイマー病治療薬のグローバル販売量、2018年-2023年 ・主要企業におけるアルツハイマー病治療薬のグローバル販売量シェア、2022年 さらに、当レポートは主要企業のプロファイルを提示します。 Allergan、 Eisai、 Novartis、 Daiichi Sankyo、 Merz Pharma、 Pfizer、 Johnson & Johnson、 Lundbeck ************************************************************* ・調査・分析レポートの概要 アルツハイマー病治療薬市場の定義 市場セグメント 世界のアルツハイマー病治療薬市場概要 当レポートの特徴・ベネフィット 調査手法と情報源 ・世界のアルツハイマー病治療薬市場規模 世界のアルツハイマー病治療薬市場規模：2022年 VS 2029年 世界のアルツハイマー病治療薬市場規模と予測 2018年-2029年 ・競争状況 グローバルトップ企業 売上ベースでのグローバルトップ企業 企業別グローバルでのアルツハイマー病治療薬の売上 グローバルトップ3およびトップ5企業、2022年売上ベース グローバル企業のアルツハイマー病治療薬製品タイプ グローバルにおけるティア1、ティア2、ティア3企業 ・タイプ別市場分析 タイプ区分：ドネペジル、メマンチン、リバスチグミン、その他 アルツハイマー病治療薬のタイプ別グローバル売上・予測 ・用途別市場分析 用途区分：初期-中期、中等度-重症 アルツハイマー病治療薬の用途別グローバル売上・予測 ・地域別市場分析 地域別アルツハイマー病治療薬市場規模 2022年と2029年 地域別アルツハイマー病治療薬売上・予測 北米市場：アメリカ、カナダ、メキシコ ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア アジア市場：中国、日本、韓国、東南アジア、インド 南米市場：ブラジル、アルゼンチン 中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE ・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど） Allergan、 Eisai、 Novartis、 Daiichi Sankyo、 Merz Pharma、 Pfizer、 Johnson & Johnson、 Lundbeck ... |
Alzheimer’s disease (AD), also referred to simply as Alzheimer’s, is a chronic neurodegenerative disease that usually starts slowly and worsens over time. It is the cause of 60% to 70% of cases of dementia.
This report aims to provide a comprehensive presentation of the global market for Alzheimer Treatment Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Alzheimer Treatment Drug. This report contains market size and forecasts of Alzheimer Treatment Drug in global, including the following market information:
Global Alzheimer Treatment Drug Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Alzheimer Treatment Drug Market Sales, 2018-2023, 2024-2029, (Units)
Global top five Alzheimer Treatment Drug companies in 2022 (%)
The global Alzheimer Treatment Drug market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Donepezil Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Alzheimer Treatment Drug include Allergan, Eisai, Novartis, Daiichi Sankyo, Merz Pharma, Pfizer, Johnson & Johnson and Lundbeck, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Alzheimer Treatment Drug manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Alzheimer Treatment Drug Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (Units)
Global Alzheimer Treatment Drug Market Segment Percentages, by Type, 2022 (%)
Donepezil
Memantine
Rivastigmine
Other
Global Alzheimer Treatment Drug Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (Units)
Global Alzheimer Treatment Drug Market Segment Percentages, by Application, 2022 (%)
Early to Moderate Stages
Moderate to Severe Stages
Global Alzheimer Treatment Drug Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (Units)
Global Alzheimer Treatment Drug Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Alzheimer Treatment Drug revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Alzheimer Treatment Drug revenues share in global market, 2022 (%)
Key companies Alzheimer Treatment Drug sales in global market, 2018-2023 (Estimated), (Units)
Key companies Alzheimer Treatment Drug sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Allergan
Eisai
Novartis
Daiichi Sankyo
Merz Pharma
Pfizer
Johnson & Johnson
Lundbeck
Outline of Major Chapters:
Chapter 1: Introduces the definition of Alzheimer Treatment Drug, market overview.
Chapter 2: Global Alzheimer Treatment Drug market size in revenue and volume.
Chapter 3: Detailed analysis of Alzheimer Treatment Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Alzheimer Treatment Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Alzheimer Treatment Drug capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
❖ レポートの目次 ❖
| ★調査レポート[世界のアルツハイマー病治療薬市場予測2023-2029：ドネペジル、メマンチン、リバスチグミン、その他] (コード：MMG23JU5642)販売に関する免責事項を必ずご確認ください。 |
| ★調査レポート[世界のアルツハイマー病治療薬市場予測2023-2029：ドネペジル、メマンチン、リバスチグミン、その他]についてメールでお問い合わせ |
